| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2013 | A preclinical evaluation of antimycin A as a potential anti-lung cancer stem cell agent | Yeh, CT; Su, CL; Huang, CY; Lin, JK; Lee, WH; Chang, PM; Kuo, YL; Liu, YW; Wang, LS; Wu, CH; Shieh, YS; Hsiao, M; Wu, AT | Evid Based Complement Alternat Med In Press | | | |
| 2022 | Aldolase A and Phospholipase D1 Synergistically Resist Alkylating Agents and Radiation in Lung Cancer | Chang, YC; Chang, PM; Li, CH; Chan, MH; Lee, YJ; Chen, MH; Hsiao, M | FRONTIERS IN ONCOLOGY 11, 811635 | | | |
| 2013 | Baseline hypertension: New insight into the potential predictors of survival in patients with hepatocellular carcinoma. | Hu, YF; Chen, TC; Chau, GY; Yang, TL; Liu, CJ; Chen, MH; Chang, PM; Chen, TJ; Hsiao, M; Huang, CY; Chen, SA | Int J Cardiol May 7 doi:pii: S0167-5273(13)00694-3. 10.1016/j.ijcard.2013.04.106. [Epub ahead of print] | | | |
| 2022 | Dehydroepiandrosterone (DHEA) Sensitizes Irinotecan to Suppress Head and Neck Cancer Stem-Like Cells by Downregulation of WNT Signaling | Li, LJ; Li, CH; Chang, PM; Lai, TC; Yong, CY; Feng, SW; Hsiao, M ; Chang, WM; Huang, CYF | FRONTIERS IN ONCOLOGY 12, 775541 | | | |
| 2008 | Expression of a soluble decoy receptor 3 in patients with diffuse large B-cell lymphoma predicts clinical outcome. | Chang, PM; Chen, PM; Hsieh, SL; Tzeng, CH; Liu, JH; Chiou, TJ; Wang, WS; Yen, CC; Gau, JP; Yang, MH | International journal of oncology 33(3), 549-54 | | | |
| 2013 | Expression of GOLM1 correlates with prognosis of human hepatocellular carcinoma | Chen, MH; Chang, PM; Hsiao, M; Jan, YH; Yeh, YC; Lei, HJ; Huang, CY; Chau, GY | Ann Surg Oncol In Revision | | | |
| 2013 | Expression of gremlin 1 correlates with increased angiogenesis and progression-free survival in patients with pancreatic neuroendocrine tumors | Chen, MH; Yeh, YC; Shyr, YM; Jan, YH; Chao, Y; Li, CP; Wang, SE; Tzeng, CH; Chang, PM; Liu, CY; Chen, MH; Hsiao, M; Huang, CY | J Gastroenterol Jan;48(1):101-108 | | | |
| 2022 | FAS receptor regulates NOTCH activity through ERK-JAG1 axis activation and controls oral cancer stemness ability and pulmonary metastasis | Li, LJ; Chang, PM; Li, CH; Lai, TC; Chang, YC; Su, CY; Chen, CL; Chang, WM; Hsiao, M ; Fung, SW | CELL DEATH DISCOVERY 8, 101 | | | |
| 2017 | Glucose transporter 4 promotes head and neck cancer metastasis through TRIM24-DDX58 axis | Chang, YC; Chi, LH; Chang, MW; Su, CY; Lin, YF; Chen, CL; Chen, MH; Chang, PM; Wu, AT; Hsiao, M | Journal of Hematology & Oncology 10(1), 11 | | | |
| 2017 | Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patients | Yeh, CN; Chang, YC; Su, Y; Hsu, DS; Cheng, CT; Wu, RC; Chung, YH; Chiang, KC; Yeh, TS; Lu, ML; Liu, CY; Chang, PM; Chen, MH; Huang, CY; Hsiao, M ; Chen, MH | Oncotarget 8(69), 113444-113459 | | | |
| 2020 | Kinase shRNA screening reveals that TAOK3 enhances microtubule-targeted drug resistance of breast cancer cells via the NF-κB signaling pathway | Lai, TC; Fang, CY; Jan, YH; Hsieh, HL; Yang, YF; Liu, CY; Chang, PM; Hsiao, M | Cell Communication and Signaling 18, 164 | | | |
| 2021 | Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 Pathway | Chung, SY; Hung, YP; Pan, YR; Chang, YC; Wu, CE; Hsu, DS; Chang, PM; Lu, ML; Huang, CY; Su, Y; Hsiao, M ; Yeh, CN; Chen, MH | BIOMEDICINES 9(8), 885 | | | |
| 2012 | Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer | Yeh, CT; Wu, AT; Chang, PM; Chen, KY; Yang, CN; Yang, SC; Ho, CC; Chen, CC; Kuo, YL; Lee, PY; Liu, YW; Yen, CC; Hsiao, M; Lu, PJ; Lai, JM; Wang, LS; Wu, CH; Chiou, JF; Yang, PC; Huang, CY | Am J Respir Crit Care Med Dec 1;186(11):1180-8 | | | |
